Details for Patent: 7,396,841

« Back to Dashboard

Which drugs does patent 7,396,841 protect, and when does it expire?

Patent 7,396,841 protects PREVACID IV and is included in one NDA.

Protection for PREVACID IV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.

Summary for Patent: 7,396,841

Title:	Injections
Abstract:	An injectable composition comprises a benzimidazole compound having an antiulcer action and a strong alkali (e.g., an alkali metal hydroxide such as sodium hydroxide) in a proportion of about 1 equivalent of the latter relative to 1 mol of the former, and is substantially free from a nonaqueous solvent. The injectable composition may comprise N-methylglucamine, and a saccharide (such as mannitol). The injectable composition may be a freeze-dried preparation. The freeze-dried preparation is dissolvable in or dilutive with a distilled water for injection or an infusion solution without a nonaqueous solvent. The injectable composition is useful as an antiulcer agent.
Inventor(s):	Doen; Takayuki (Suita, JP), Nagao; Masao (Kashiba, JP), Asakawa; Naoki (Takatsuki, JP), Takechi; Nobuyuki (Osaka, JP)
Assignee:	Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:	10/344,805
Patent Claim Types: see list of patent claims	Composition; Compound; Formulation; Process; Use;

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	RS	Patent No.	Patent Expiration	Delist Req.
Takeda Pharms Na	PREVACID IV	lansoprazole	INJECTABLE;INTRAVENOUS	021566-001	May 27, 2004	DISCN	Yes	No	7,396,841*PED	► Subscribe	Y

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,396,841

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2000-248468	Aug 18, 2000

PCT Information
PCT Filed	August 17, 2001	PCT Application Number:	PCT/JP01/07075
PCT Publication Date:	February 28, 2002	PCT Publication Number:	WO02/15908

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 7,396,841

« Back to Dashboard

Summary for Patent: 7,396,841

Glossary

Foreign Priority and PCT Information for Patent: 7,396,841

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Get our Free Drug Patent Bulletin